WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS

Mark Identification

Proof of use for DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS

We do not have any records of a proof of use for DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS at this moment.

Click here to add a proof of use for DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS

Possible trademark infringements of DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS

Basic Information about DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS

Serial Number
79136684
Filing Date
19 Jul 2013
Mark Drawing Code
3

Classifications

Declare the trademark use of DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS on the blockchain with WikiTrademarks.io.

First use of DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
H
International Code
035
US Codes
100; 101; 102
First use of DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
H
International Code
042
US Codes
100; 101
First use of DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
H
International Code
044
US Codes
100; 101
First use of DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS anywhere
No first use declared yet.
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
H
International Code
045
US Codes
100; 101

Who owns DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS?

Correspondent

Debiopharm International SA
Forum "après-demain"
Chemin Messidor 5-7
CH-1002 Lausanne

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on DEBIOPHARM GROUP WE DEVELOP FOR PATIENTS